ALNY Stock Analysis: Buy, Sell, or Hold?

ALNY - Alnylam Pharmaceuticals, Inc.

PHARMACEUTICAL PREPARATIONS
$236.01
-0.21 (-0.09%) â–ŧ
5d: +5.08%
30d: -13.16%
90d: -20.66%
WAIT
LOW Confidence
Protect Your ALNY Gains
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Jul 30, 2026 0d

Get Alerted When ALNY Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: ALNY is fairly priced but lacks strong directional signals. At -9.2% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$612.79
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$380.50
38.0% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ALNY is currently trading at $236.01, which is considered fair relative to its 30-day fair value range of $216.03 to $268.63. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.8) compared to its historical average (25.0). Remarkably, the market is currently pricing in an annual earnings decline of 9.2% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, ALNY is in a strong downtrend. Immediate support is located at $216.50, while resistance sits at $244.03.

Market Sentiment: ALNY scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $370.20 (+56.9%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $216.03 - $268.63
Company Quality Score 42/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 83.3%

Protect Your Profits

Holding ALNY? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (65/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 56.9% below Wall St target ($370.20)
  • WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $216.03 - $268.63
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $216.50
Resistance Level $244.03
Current Trend Strong Downtrend
Technical data as of Aug 24, 2026

Fundamental Context

Forward P/E (Next Year Est.) 18.75
Wall Street Target $370.20 (+56.9%)
Revenue Growth (YoY) 66.9%
Profit Margin 16.1%
Valuation Discount vs History -9.2% cheaper
PE vs Historical 18.8 vs 25.0 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -9.2% (market-implied from PE analysis)
1-Year Target $214.30 (-9%)
2-Year Target $194.58 (-18%)
3-Year Target $176.68 (-25%)
3-Yr Target (if PE normalizes) (PE: 19→25) $235.57 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.1, Growth: 41.2%) $710.25 (+201%)
Base: (SPY PE: 18.8, Growth: 41.2%) $664.19 (+181%)
Bear: (PE: 15.9, Growth: 41.2%) $564.57 (+139%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (41x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 41.15 | Current EPS (TTM): $5.74
Bull Case $519.68 (+120%)
Analyst growth 100.0%, PE expands to 45.3
Base Case $472.44 (+100%)
Market implied 100.0%, PE stable at 41.2
Bear Case $160.63 (-32%)
Severe decline -20.0%, PE contracts to 35.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.8 to 25.0
Stabilization Target: $314.68 (+33.3%)
PE Expansion Potential: +33.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 24, 2026 6:31 PM ET
Data refreshes hourly during market hours. Next update: 7:31 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Melissa Mclaughlin SELL 2286 shares 2026-04-06
Melissa Mclaughlin SELL 1624 shares 2026-04-02
Kevin Joseph Fitzgerald SELL 1652 shares 2026-03-03

Unlock Insider Activity

See real-time buying/selling by company executives for ALNY.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$433 38 SELL
VRTX
Vertex Pharmaceuticals Iâ€Ļ
BUY
34 analysts
$560 30 SELL
ASND
Ascendis Pharma AS
STRONG BUY
16 analysts
$313 50 HOLD
APLS
Apellis Pharmaceuticals â€Ļ
BUY
22 analysts
$41 50 HOLD
VERA
Vera Therapeutics Inc
STRONG BUY
14 analysts
$77 49 HOLD

Advanced ALNY Option Strategies

Professional options setups generated by AI based on today's ALNY price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ALNY

ALNY Technical Chart ALNY Price Prediction ALNY Earnings Date ALNY Investment Advisor ALNY Fair Price Analyzer ALNY Options Advisor ALNY Options Chain ALNY Options Analysis ALNY Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals